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Compared to standard exercise tolerance testing, cardiopulmonary exercise testing is a 
reliable and powerful tool that can be used for risk stratification, exercise prescription and 
clinical diagnosis. 
 
Introduction 
Cardiopulmonary exercise testing (CPX or CPET) is a physiological investigation that offers 
the clinician a wealth of information, beyond that obtainable from standard exercise 
tolerance testing (ETT). It provides a ‘global’ assessment of the cardiovascular, ventilatory, 
and metabolic responses to exercise, and when used correctly, is a powerful diagnostic and 
prognostic tool.  
 
Multiple factors contribute to exercise intolerance across a wide spectrum of patients with 
cardiovascular disease and establishing the aetiology and prognostic importance of this 
intolerance is a significant challenge for clinicians. The purpose of this 2-part guide is to 
review the rationale for CPET; define and interpret key CPET variables; and provide clinicians 
with practical guidelines to aid clinical decision-making and patient management. The 
present article is intended to provide an introduction and orientation to CPET, its key 
principles and test preparation considerations.  
 
Cardiopulmonary exercise testing combines maximal or symptom-limited progressive 
intensity exercise with ventilatory expired gas analysis. It is the breath-by-breath monitoring 
of oxygen ( ) and carbon dioxide () during exercise that enables accurate assessment of a 
patient’s functional capacity and the underlying aetiology of exercise limitation. Since the 
direct measurement of ventilatory expired gas is both reliable and reproducible it 
overcomes the many inaccuracies associated with estimating a patient’s aerobic capacity 
from submaximal exercise testing, via for example, a 6-minute walk or incremental shuttle 
walk test. 
 
It should be emphasised that the interpretive power of CPET in clinical decision-making lies 
in the integrated analysis of cardiorespiratory variables. Exercise capacity is not likely to be 
limited by any single component of the  transport/utilisation process, but rather, the co-
existence of cardiovascular and respiratory abnormalities and their interactions. 
Cardiopulmonary exercise testing can meaningfully quantify these interactions and in 
conjunction with other features of importance during exercise, such as electrocardiographic 
(ECG) changes and perceptual responses (symptoms), can optimise clinical interpretation of 
exercise intolerance. 
In contrast to traditional ETT, which has been shown to have poor sensitivity and specificity 
for myocardial ischaemia detection (Belardinelli et al., 2003), CPET is not reliant upon 
ischaemic ECG changes. Gas exchange is able to identify abnormal haemodynamic 
responses to exercise through changes in key cardiopulmonary exercise test variables (e.g. 
the attenuation of stroke volume [SV] and cardiac output) during exercise by observing 
changes in key CPET variables, such as  pulse (/heart rate), a surrogate marker of SV. An 
observed abnormality in  pulse is likely to become evident earlier than the appearance of ST 
segment depression on ECG or symptoms of angina (Chaudhry et al., 2009).  
 
The contribution of CPET can be appreciated across a wide spectrum of clinical settings 
however its most common indications include those depicted in Box 1. 
 
 
 
 
 
 
 
 
Data Capture 
The integrative response of the cardiorespiratory system to increasing work rate during 
CPET is recorded in real time by computer-linked analysers and displayed graphically in a 
Wasserman nine-panel plot. These plots and their underlying principles have been 
Box 1: Indications for CPET 
a) Pre-operative assessment   
b) Evaluation for heart-lung transplantation 
c) Prognostic assessment and risk stratification 
d) Evaluation of exercise intolerance and functional exercise capacity 
e) Evaluation of disease severity and/or progression 
f) Exercise prescription for rehabilitation  
g) Determining effectiveness of pharmacological agents/exercise intervention 
 
 
developed by Wasserman and colleagues over the past 30-40 years. They remain the pre-
eminent tool for CPET interpretation, however it should be noted that the configuration of 
the 9 panels has been recently revised in the fifth edition of the textbook (Wasserman et al., 
2011). Detailed description of the exercise physiology underpinning these plots is beyond 
the scope of this guide, with explanation and interpretation limited to only that of key CPET 
variables. The interested reader is directed to Wasserman et al. (2011) and other published 
guidelines (Balady et al., 2010; Mezzani et al., 2009) for more detailed elucidation.  
The key variables obtained during CPET include; oxygen uptake ( ), minute ventilation (VE), 
carbon dioxide production ( ), and heart rate (HR). However from these central variables, a 
number of other prognostically important markers of cardiorespiratory function can also be 
derived (Table 1). 
 
Table 1. CPET v Standard exercise tolerance test (ETT) variables  
 
Clinical Standard CPET Standard ETT 
 
Standard ETT markers plus: 
Peak Oxygen Uptake ( ) 
Maximal Oxygen Uptake ( ) 
Respiratory Exchange Ratio (RER) 
Ventilatory Anaerobic Threshold (VAT) 
 Ventilatory Efficiency (VE/  slope) 
Oxygen Uptake Efficiency Slope (OUES) 
Oxygen Pulse ( /HR) 
 
  
HR Recovery  
Estimated METs 
ECG morphology 
 
Maximal exercise testing with integrated gas exchange is a safe procedure, even in 
populations with higher underlying risk diagnoses; including heart failure, hypertrophic 
cardiomyopathy, pulmonary hypertension, aortic stenosis, and chronic obstructive 
pulmonary disease (Skalski, Allison, & Miller, 2012). Reported rates of death for patients 
during maximal exercise testing are approximately 2 to 5 per 100,000 clinical exercise tests 
(Balady et al., 2010). Although event rates are low regardless of patient population, 
complications resulting from maximal exercise testing can occur, therefore absolute and 
relative contraindications for CPET should be observed (Table 2).  
Table 2. Absolute and relative contraindications for CPET 
 
Absolute Relative 
Acute Myocardial Infarction (3–5 Days) 
Unstable Angina 
Uncontrolled arrhythmias causing symptoms or 
Haemodynamic compromise 
Syncope 
Active endocarditis  
Acute myocarditis or pericarditis  
Symptomatic severe aortic stenosis 
Uncontrolled Heart Failure 
Acute pulmonary embolus or pulmonary 
Infarction 
Thrombosis of lower extremities  
Suspected dissecting aneurysm 
Uncontrolled asthma 
Pulmonary oedema 
Ambient  desaturation at rest < 85% 
Respiratory failure 
Acute non-cardiopulmonary disorder that may 
affect exercise performance or be aggravated by 
exercise  
Mental impairment leading to inability to 
cooperate 
Left main coronary stenosis or its equivalent  
Moderate stenotic valvular heart disease  
Severe untreated arterial hypertension at rest 
(>200 mm Hg systolic, >120 mm Hg diastolic) 
Tachyarrhythmias or bradyarrhythmias 
High-degree atrioventricular block 
Hypertrophic cardiomyopathy 
Significant pulmonary hypertension 
Advanced or complicated pregnancy 
Electrolyte abnormalities 
Orthopaedic impairment that compromises 
exercise performance 
 
 
 
 
Conducting a CPET 
General methodological guidelines for CPET are available (American Thoracic 
Society/American College of Chest Physicians, 2003; Myers et al., 2009) however the 
following pre-test practices are recommended (Box 2): 
 
 
 
 
 
Protocol Selection  
Box 2: Pre-Test Considerations  
• Patient consent 
• Protocol selection and full explanation of test protocol  
• History and clinical examination 
• Compliance with pharmacological treatments 
• Assessment of co-morbidities e.g. orthopaedic limitations  
• Anthropometric measurements: height, weight, waist-hip ratio, body mass index, 
body composition (% lean mass and fat mass) 
• Resting ECG: resting heart rate, sinus rhythm or atrial fibrillation 
• Pre-test spirometry 
 
 
The goal of CPET is to interrogate the cardiorespiratory system under increasing physical 
stress. The selection of an appropriate exercise test protocol therefore is an important 
consideration. Several protocols can be used with either a cycle ergometer or motorised 
treadmill, but both should employ a progressively increasing workload.  
Since the responses of key variables of interest ( ,  and VE) lag behind changes in work 
rate, incremental protocols that involve small to modest work rate increments per stage are 
preferred e.g. Naughton (Naughton, Sevelius, & Balke, 1963) or Balke (Balke & Ware, 1959) 
(Balke and Ware, 1959). Alternatively, continuous ramp (where work increments are 
negligible) or pseudo-ramp protocols (where typically work rate will increase at 10-60 sec 
intervals, often in 5W-20W increments) help to maintain a more constant rate of work 
increase and therefore better preserve the relationship between  and work rate (Myers et 
al., 1991). Protocols with large work-rate increments e.g. Bruce and Modified Bruce 
(American College of Sport Medicine, 2014) may lead to rapid lactate accumulation and 
therefore premature cessation of effort during exercise. Indeed, Ingle and colleagues (2008) 
showed that 42% of patients with suspected chronic heart failure were unable to complete 
a maximal CPET (defined as a peak RER>1.0) when undertaking a Modified Bruce protocol.  
Initial exercise workloads should be individualised according to a patient’s perceived 
exercise capacity and clinical circumstances, in order to elicit volitional exhaustion after 8 - 
12 minutes (regardless of baseline fitness level). Avoiding unnecessarily prolonged or 
prematurely terminated exercise is important if a “true”  and the source of exercise 
limitation is to be accurately established (Box 3). 
Within the clinical setting treadmill exercise is still common, since for most patients walking 
is a more familiar activity than cycling. However, cycle ergometry has become increasingly 
popular, particularly for those patients who are obese or have severe orthopaedic 
limitations, gait or balance instability. Though it should be noted that  during cycling is 
systematically 10-20% lower than that achieved during treadmill exercise (Myers et al., 
1991) Cycling performance is often limited by localised leg fatigue and because it is non-
weight bearing, metabolic demand is lower.  
 
Equipment Calibration  
Irrespective of the metabolic cart used for CPET data capture, adherence to calibration and 
quality assurance procedures is crucial for accurate measurement of metabolic gas 
exchange and valid test interpretation. Although individual calibrations and manufacturers 
recommendations will differ, all systems should be calibrated immediately before each test 
for known gas volumes and concentrations. The reader is referred to the Scientific 
Statement from the American Heart Association published in 2010, where a comprehensive 
overview of the procedures for calibration of gas exchange systems is presented (Balady et 
al., 2010). 
 
Pre-CPET Spirometry  
Spirometry is an effective tool in establishing whether ventilatory limitation is a primary 
cause or contributor to exercise intolerance. Forced spirometry manoeuvres including 
forced expiratory volume in one second ( ); forced vital capacity (FVC); and peak expiratory 
flow (PEF) are therefore also required to substantiate the extent of any respiratory 
limitation during CPET. All these variables can be obtained from a resting flow volume loop, 
conducted in accordance with the standards published by the American Thoracic 
Society/European Respiratory Society (2005). 
The ratio of  to FVC ( /FVC) is a widely accepted index of resting pulmonary function; with a 
value less than 0.70 indicating obstructive (flow-related) respiratory disease (National 
Insitute for Health and Care Excellence, 2010; Wasserman et al., 2011). However, resting 
lung function alone will not sufficiently predict the extent to which respiratory disease limits 
exercise capacity. Maximum voluntary ventilation (the maximum volume of air ventilated in 
60 seconds) and breathing reserve (BR), derived from CPET, can aid in the determination of 
normal respiratory function.  
Maximum voluntary ventilation (MVV) is a parameter calculated at rest and is commonly 
estimated (eMVV) by the formula  x 40 (Blackie et al., 1991). Breathing reserve is the 
difference between eMVV and the maximum exercise ventilation ( ) recorded during CPET. 
In healthy individuals, exercise capacity will be rarely affected by respiratory limitation since 
respiratory capacity far exceeds the demands of peak exercise. In such cases, a normal BR at 
peak exercise (>20% of MVV) will be observed (Balady et al., 2010). In contrast, patients 
whose exercise is limited by respiratory disease will have a BR close to zero at peak exercise, 
since cardiovascular efficiency surpasses respiratory efficiency.  
It should be noted that in the presence of certain respiratory diseases, such as dynamic 
hyperinflation, BR cannot be reliably determined by the formula  x 40, and therefore 
precludes the determination of ventilatory limitation via standard pre-CPET spirometry.  
 
Determination of maximal effort and test termination 
The verification of a maximal effort is crucial for accurate CPET interpretation, particularly 
where a patient’s  is reduced and clear physiologic limitation is not elicited during 
exercise. Patients should be encouraged to exercise until a “true” symptom-limited maximal 
effort is achieved. Whilst there is currently no gold standard evaluation of maximal effort, 
one may be confirmed if the patient attains two of the following criteria* (Box 3):  
 
 
 
 
 
 
 
 
 
Footnote: *It should be noted that despite maximal effort, patients often fail to achieve a 
plateau in oxygen uptake during peak exercise.  We suggest that peak RPE and peak RER are 
used, which may be substantiated by examining additional variables such as blood lactate, if 
routinely collected (ACSM, 2014). 
 
Achieving a clear plateau in  has traditionally been considered the best evidence of  max 
(the highest achievable level of oxidative metabolism involving large muscle groups) and 
thus the gold standard index of cardiorespiratory fitness. Yet as indicated, patients may 
Box 3: Maximal Effort Criteria  
• Failure of HR to increase with further increases in exercise intensity (achieving 
>85% of age-predicted maximal HR is a well-recognised indicator of patient effort) 
• A plateau in O2 (or failure to increase by 150 mL.min-1) with an increased 
workload 
• A respiratory exchange ratio (RER = CO2/ O2) at peak exercise > 1.10  
• A rating of perceived exertion (RPE) > 17 on the 6-20 Borg scale or >9 on the 0-10 
 
         
often fail to achieve a plateau in , despite maximal effort. The term  (an accepted 
estimate of  max) is therefore preferred when defining the limits of the cardiorespiratory 
system. 
 
Conclusion 
This article has sought to provide an introduction to CPET, summarise the basic and 
essential parameters that can be derived from it and illustrate its clinical value when 
evaluating patients with, or suspected of having, cardiovascular or respiratory disease. Part 
two of this guide will focus specifically on CPET data interpretation and the application of 
CPET findings for the purposes of patient diagnosis and risk stratification.   
 
 
Key Points 
 
1. Multiple factors contribute to exercise intolerance across a wide spectrum of patients; 
establishing the aetiology and prognostic importance of these limitations is a significant 
challenge for clinicians. 
 
2. When combined with the standard tools of clinical investigation, the cardiopulmonary 
exercise test is the “gold standard” method for objectively assessing cardiorespiratory 
physiology 
 
3. Cardiopulmonary exercise testing offers a more comprehensive assessment of 
cardiorespiratory function than standard exercise tolerance tests  
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